Results 181 to 190 of about 9,755,316 (348)

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

open access: yesMolecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop   +10 more
wiley   +1 more source

Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapy

open access: hybrid, 1996
Christopher P. Denton   +3 more
openalex   +1 more source

Chromosomes are target sites for photodynamic therapy as demonstrated by subcellular laser microirradiation [PDF]

open access: green, 2000
Liang Hong   +7 more
openalex   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

open access: yesMolecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed   +8 more
wiley   +1 more source

Succinate supplementation alleviates liver cancer by inhibiting the FN1/SQLE axis-mediated cholesterol biosynthesis

open access: yesiScience
Summary: Succinate is a crucial metabolite in the TCA cycle and contributes to cancer development. However, the role of exogenous succinate in hepatocellular carcinoma (HCC) is unclear.
Shuyuan Chang   +12 more
doaj  

MET-dependent solid tumours — molecular diagnosis and targeted therapy

open access: yesNature Reviews Clinical Oncology, 2020
Robin Guo   +5 more
semanticscholar   +1 more source

Loss of primary cilia promotes EphA2‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment

open access: yesMolecular Oncology, EarlyView.
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho   +11 more
wiley   +1 more source

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

open access: yesCell, 2020
Karsten Krug   +94 more
semanticscholar   +1 more source

Emerging mechanisms and targeted therapy of ferroptosis in cancer.

open access: yesMolecular Therapy, 2021
Haiyan Wang   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy